NO964667L - Purin-6-on-derivater - Google Patents

Purin-6-on-derivater

Info

Publication number
NO964667L
NO964667L NO964667A NO964667A NO964667L NO 964667 L NO964667 L NO 964667L NO 964667 A NO964667 A NO 964667A NO 964667 A NO964667 A NO 964667A NO 964667 L NO964667 L NO 964667L
Authority
NO
Norway
Prior art keywords
derivatives
formula
purin
stands
residue
Prior art date
Application number
NO964667A
Other languages
English (en)
Norwegian (no)
Other versions
NO964667D0 (no
Inventor
Ulrich Niewoehner
Erwin Bischoff
Joachim Huetter
Elisabeth Perzborn
Helmuth Schuetz
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO964667D0 publication Critical patent/NO964667D0/no
Publication of NO964667L publication Critical patent/NO964667L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO964667A 1995-11-06 1996-11-05 Purin-6-on-derivater NO964667L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19541264A DE19541264A1 (de) 1995-11-06 1995-11-06 Purin-6-on-derivate

Publications (2)

Publication Number Publication Date
NO964667D0 NO964667D0 (no) 1996-11-05
NO964667L true NO964667L (no) 1997-05-07

Family

ID=7776713

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964667A NO964667L (no) 1995-11-06 1996-11-05 Purin-6-on-derivater

Country Status (23)

Country Link
US (1) US5861396A (sk)
EP (1) EP0771799A1 (sk)
JP (1) JPH09124648A (sk)
KR (1) KR970027082A (sk)
AR (1) AR004545A1 (sk)
AU (1) AU720305B2 (sk)
BR (1) BR9605434A (sk)
CA (1) CA2189401A1 (sk)
CO (1) CO4770977A1 (sk)
CZ (1) CZ325096A3 (sk)
DE (1) DE19541264A1 (sk)
EE (1) EE9600172A (sk)
HU (1) HU217691B (sk)
IL (1) IL119559A0 (sk)
MX (1) MX9605371A (sk)
NO (1) NO964667L (sk)
NZ (1) NZ299683A (sk)
PL (1) PL316816A1 (sk)
SG (1) SG64953A1 (sk)
SK (1) SK142596A3 (sk)
TR (1) TR199600883A2 (sk)
TW (1) TW360656B (sk)
ZA (1) ZA969278B (sk)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39112E1 (en) * 1998-01-05 2006-05-30 Eisai Co., Ltd. Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes
DE19838705A1 (de) * 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
US20050070499A1 (en) * 1999-11-08 2005-03-31 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
IL139457A0 (en) * 1999-11-08 2001-11-25 Pfizer Compounds for the treatment of female sexual dysfunction
EP1307201B1 (de) * 2000-08-01 2004-11-24 Bayer HealthCare AG Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
WO2002020058A1 (fr) * 2000-09-06 2002-03-14 Tanabe Seiyaku Co., Ltd. Preparations administrees par voie orale
DE10064105A1 (de) 2000-12-21 2002-06-27 Bayer Ag Neue Substituierte Imidazotriazinone
CN100372536C (zh) * 2001-02-15 2008-03-05 田边三菱制药株式会社 在口腔中迅速崩解的片剂
EP1379520B2 (en) 2001-02-23 2014-04-09 Merck Sharp & Dohme Corp. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
WO2003037432A1 (en) * 2001-11-02 2003-05-08 Pfizer Products Inc. Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
CA2517336A1 (en) * 2003-03-04 2004-10-21 Altana Pharma Ag Purin-6-one-derivatives
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
WO2005021037A1 (en) * 2003-08-28 2005-03-10 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde2 inhibitor
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
CA2602383A1 (en) * 2005-03-21 2006-09-28 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
ATE412648T1 (de) * 2005-03-21 2008-11-15 Pfizer Ltd Substituierte triazolderivate als oxytocinantagonisten
US20100222365A1 (en) * 2005-08-10 2010-09-02 Pfizer Inc Substituted triazole deriviatives as oxytocin antagonists
US9849132B2 (en) 2014-01-08 2017-12-26 Intra-Cellular Therapies, Inc. Products and pharmaceutical compositions
MX2017007377A (es) 2014-12-06 2017-11-06 Intra-Cellular Therapies Inc Compuestos organicos.
BR112017012007B1 (pt) 2014-12-06 2022-11-01 Intra-Cellular Therapies, Inc Compostos orgânicos inibitórios de pde2, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento de um distúrbio mediado por pde2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
IL76546A (en) * 1984-10-12 1988-12-30 Warner Lambert Co 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them
JPH01501478A (ja) * 1986-11-25 1989-05-25 インスティテュト　オルガニチェスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスアール ９―置換グアニン
IT1241452B (it) * 1990-06-28 1994-01-17 Sigma Tau Ind Farmaceuti Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
DE19541264A1 (de) 1997-05-07
EP0771799A1 (de) 1997-05-07
EE9600172A (et) 1997-06-16
NZ299683A (en) 1998-09-24
HUP9603071A2 (en) 1997-05-28
CA2189401A1 (en) 1997-05-07
CO4770977A1 (es) 1999-04-30
NO964667D0 (no) 1996-11-05
SK142596A3 (en) 1997-05-07
BR9605434A (pt) 1998-08-04
AU720305B2 (en) 2000-05-25
ZA969278B (en) 1997-06-02
KR970027082A (ko) 1997-06-24
TW360656B (en) 1999-06-11
AU7053296A (en) 1997-05-15
PL316816A1 (en) 1997-05-12
CZ325096A3 (en) 1997-06-11
MX9605371A (es) 1997-05-31
HU217691B (hu) 2000-03-28
US5861396A (en) 1999-01-19
SG64953A1 (en) 1999-05-25
JPH09124648A (ja) 1997-05-13
AR004545A1 (es) 1998-12-16
HU9603071D0 (en) 1996-12-30
TR199600883A2 (tr) 1997-05-21
HUP9603071A3 (en) 1998-04-28
IL119559A0 (en) 1997-02-18

Similar Documents

Publication Publication Date Title
NO964667L (no) Purin-6-on-derivater
HUT36840A (en) Process for producing 11-beta-estradiene derivatives and pharmaceutical compositions containing them
MX9203762A (es) Administracion de monoaminacridinas en estados deficientes en colinergicos-neuronales.
MY102866A (en) Amide derivatives.
IL143978A0 (en) Colchinol derivatives as vascular damaging agents
NO954453L (no) Nye pyridin-, pyrimidin- og benzenderivater som adreno-ceptorantagonister
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
ATE250623T1 (de) 4'-c-ethynyl-purin-nukleoside
UA41869C2 (uk) Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування
DE3873870T2 (de) Androstan-17-carbonsaeureester, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.
ATE90676T1 (de) Dioxyalkylenaryl-dihydropyridine zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung.
DE68923151T2 (de) Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen.
ATE44748T1 (de) 4-substituierte 6-alkylidene-androsten-3,17-dion- derivate und verfahren zu ihrer herstellung.
ES2011427A4 (es) Derivados de oxina de octahidronaftaleno para inhibicion de la sintesis del colesterol, procesos para su preparacion y composiciones que los contienen.
DE69719511T2 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
ES2152563T3 (es) Procedimiento para preparar derivados de dihidroxipirimidina.
MX9708735A (es) Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos.
DE3480839D1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
ATE5961T1 (de) N-acylpeptid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
TR200003877T2 (tr) İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri
HUT64302A (en) Method for producing octahydro-naphtaline-oxime derivatives inhibiting biological synthesis of cholesterol and medical preparatives containing them
NO963374L (no) Substituerte 4H-pyraner
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
BG102429A (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means
GR3034439T3 (en) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof